interferon by its temperature of inactivation, trypsin sensitivity, nonsedimentability, stability at pH 2, lack of inactivation by antibody to virus, and inability to be washed off cells. In the more distantly related chicken and monkey cells, mouse interferon had less than 0.1 of its homologous activity. Conflicting reports of heterologous activity of chicken and mouse interferon preparations may result in part from the observed action of noninterferon inhibitors of vaccinia virus. These inhibitors, like interferon, are stable at pH 2. They are present in mouse serum, mouse lung extracts, and allantoic fluid, and they prevent the development of vaccinia plaques when allowed to remain in contact with cells during virus growth. Unlike interferon the inhibitors are removed by adequate washing of cells prior to virus challenge, and they are not active in the VSV assay system. These findings reemphasize the need for thorough characterization of interferon preparations.
The property of species specificity of interferon was first reported by Tyrrell (30) , when he showed that calf and chick interferon failed to induce antiviral activity on heterologous cells. This unusual property of these antiviral proteins, that of exhibiting their strongest activity on homologous cells, has been demonstrated for interferons prepared in many different cell types [reviewed by Isaacs (15) ]. However, the barrier against heterologous activity has not always been reported to be absolute (15) . Reports of heterologous activity of chick and mouse interferon (8, 29) differ with findings of a strong barrier between these species (3, 21) .
The present report extends studies on the specificity of action of mouse serum interferon. The antiviral activity of this interferon on rat, hamster, and monkey cells was studied. A noninterferon inhibitor of vaccinia virus was also investigated. This inhibitor possibly explains the 1 This work was presented in part at the 49th Annual Meeting of the Federation of American Societies for Experimental Biology, Atlantic City, N.J., 1965. reported heterologous activity between chick and mouse interferon preparations.
MATERIALS AND METHODS
Tissue cultures. Primary cultures of 9-day-old chick embryos (CE), and near term mouse (ME), rat (RE), or hamster (HE) embryos were used. Cells were grown in Eagle's medium (MEM) with 10% serum and antibiotics. Calf serum was used with CE cultures and horse serum was used with ME, RE, and HE cultures. (20) was used to determine antiviral activity. Modifications of this procedure are described in Results.
Characterization of antiviral activity as interferon. The properties of the viral inhibitory activity of mouse interferon on RE and HE cells were determined as described previously (2). Table 1 shows titers obtained for several mouse interferon preparations, containing different (Table 2) . As with RE assays, the variations in the ratios of heterologous to homologous activity (1:16 to 1:30) were within the expected interassay variation, and an average ratio of 1:20 was found. As can be seen from the homologous titers of various mouse interferon preparations shown in Tables 1 and 2 , amounts produced in mouse serum may vary over a large range. However, the heterologous activity tended to parallel the homologous activity.
RESULTS
To determine that the antiviral activity of mouse interferon on RE and HE cells was produced by interferon, mouse interferon preparations were treated as shown in Table 3 , and were assayed on ME, RE, or HE cells. Since all mouse serum interferon preparations were treated with acid to destroy residual NDV, the heterologous activity was stable at pH 2. Heating at 44 C for 1 hr did not reduce activity, whereas heating at 56 C for 1 hr partially reduced both the homologous serum, whereas VSV was not significantly inhibited by either of these preparations.
A major difference between the two assay techniques is that with the vaccinia virus assay system interferon is allowed to remain in contact with cells during the entire period of viral adsorption and plaque development. Extracellular inhibitors of vaccinia virus, therefore, have an opportunity to react with the challenge virus. To test for the influence of such inhibitors, a modification of the vaccinia virus assay system was employed. Amounts of 1 ml of dilutions of various interferon preparations or suitable control fluids were incubated with CE cells for 3 hr at 37 C. Controlled experiments had determined that the maximal antiviral effect of interferon was obtained by this time. The plates were then divided into two groups. To one group an additional 1 ml of Eagle's medium was added and then 0.2 ml of challenge virus. The other group of plates were decanted and washed five times with 3 ml of Earle's balanced salt solution (BSS). After washing, the plates were refed with 2 ml of Eagle's medium and 0.2 ml of virus challenge was added. Figure 1 shows the results obtained when mouse interferon or normal control mouse serum was assayed. With assays using unwashed cells, both mouse interferon and normal control mouse serum inhibited vaccinia plaques. Washing removed this inhibition, indicating that the effect was not due to interferon. When 20% mouse lung extracts, from mice previously inoculated intranasally with either yeast nucleic acid or Earle's BSS (Takano et (Fig. 2) . The vaccinia inhibitory activity was removed by thorough washing prior to challenge. These same prepara- tions had previously been tested in a homologous ME-VSV assay system and were found to contain less than 0.3 units of interferon per ml. Additional control experiments showed that thorough washing of CE, ME, RE, or HE plates prior to VSV challenge has no effect on the number of plaques produced, indicating the absence of noninterferon inhibitors of VSV.
In a homologous CE assay, nomnterferon vaccinia inhibitors were also demonstrated by comparison of the inhibition of vaccinia virus plaque formation on washed and unwashed plates (Fig.  3) . With a vaccinia virus assay on plates washed to remove noninterferon inhibitors, it was found that vaccinia virus 'gave a 50% reduction end point at 30 units per ml for. preparations which had a VSV titer of 300 units per ml. Vaccinia virus, therefore, is significantly less sensitive to interferon than is VSV. The noninterferon inhibitor of vaccinia virus, like interferon, is stable at pH 2. Unlike interferon, it is present in normal allantoic fluid.
DIscussioN
The present study demonstrated that mouse serum interferon exhibits antiviral activity on RE and HE cells but not on MT cells. This antiviral substance has similar propetties in heterologous and homologous assays. Previously reported heterologous activity between mouse and'hamster interferons was not, completely. characterized (11) . That the extent of the genetic relationship between two species may determine the ability of their interferon to exhibit heterologous activity is suggested by the reported heterologous activity-between human and monkey systems (4, 10, 16, 24, 28) and by the present report of the activity of mouse interferon on hamster and rat cells.
One important aspect of any interferon assay is establishing that the antivirlil activity observed is actually due to interferon. Heterologous activity of mouse and chick interferon has been reported when a vaccinia interferon assay system was used (1, 8, 29 (27, 28) . The rather common occurrence, of noninterferon inhibitors (9, 13) necessitates a complete characterization of the heterologous antiviral activity before acceptance as interferon.
Similar controls would be necessary to confirm the single report of heterologous activity of interferons produced in several mammalian cell types (24) and the report of activity of mouse cellproduced interferon on human kidney cells (12) .
The use of purified interferot preparations 
